Sater et al. [34] reported that neoadjuvant prostate specific-antigen (PSA)-targeted vaccination with PROSTVAC prior to radical prostatectomy enhanced T cell infiltration into the tumor microenvironment of PCs. The gene discussed is KLK3; the disease is neoplasm.